logo-supreme-whiteSupreme Pharmaceuticals, Inc, alternatively known as Supreme Pharma and Bioscience, is a former mining company and current biomedicine company in Canada. Its particularly delves on medical marijuana, with a greenhouse in Ontario and preparations underway for online product sales.

The company’s history goes way back to 1979, when it was founded. It went through various businesses and names such as Sonar Energy Company, US Platinum, Inc, and Universal Energy Corp. In 2007, it became Supreme Resources, Ltd, a junior mineral exploration company operating in BC for base and precious metals. Finally, in March 2014, the company pursued its new direction and became Supreme Pharmaceuticals, Inc.

Supreme Pharma is now on the Canadian Stock Exchange under the symbol SL, and on the US OTC markets under the symbol SPRWF. Its market cap is around USD 22.91 M.

The flagship of Supreme Pharma is the Supreme Greenhouse located in Kincardine, Ontario. Covering a total of 342,000 square feet, the facility will allot 280,000 square feet for growing cannabis and over 6,000 square feet for research and development. Supreme emphasizes that unlike many marijuana grow operations, which cultivate the plant indoors, the Supreme Greenhouse will use natural sunlight and supplement it with state-of-the-art equipment.

The company is now preparing to sell its marijuana products online, with an online shop and a customer discount program named CanAssist.

Supreme Pharma’s grow operations started with is acquisition of Advanced Medical Marijuana Canada (AMMCan). Preapproved by Health Canada, AMMCan may produce and distribute up to 24,000 kilograms of marijuana annually. After it became Supreme Pharma’s wholly owned subsidiary, AMMCan is now called Supreme Medical Marijuana (AMMCan Supreme).

Supreme Pharmaceuticals, Inc is led by Chairman, President, and CEO David Stadnyk, Executive VP Brayden R. Sutton, and Production Advisor Thaddeus Conrad. AMMCan executives meanwhile include CEO Peter M. Herburger, Director of Operations John Fowler, and Medical Director Dr. Kenneth Adams.


Yahoo! Finance: SPRWF News

Latest Financial News for SPRWF

BMO Analysts Initiate Supreme Cannabis -- CFN Media

SEATTLE, March 18, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing The Supreme Cannabis Company (FIRE.TO) (SPRWF) (53S1.F). The cannabis industry may have been dominated by microcaps a couple years ago, but multi-billion dollar valuations, blue chip investments, cannabis-focused ETFs, and growing analyst coverage is helping it reach a new level of maturity. The wider market is finally starting to realize the cannabis industry’s significant potential in both medicinal markets, as a pharmaceutical alternative, and recreational markets, as an alcohol or tobacco alternative.

GMP Securities Upgrades Aurora Cannabis to a ‘Buy’

GMP Securities Upgrades Aurora Cannabis to a 'Buy'Aurora Cannabis upgradedGMP Securities, which previously had a “hold” rating on Aurora Cannabis (ACB), upgraded the company to a “buy” on March 13. The company also gave ACB a price target of

Must-Read Cannabis Sector Valuation Multiples before Investing

TLRY Is Too Rich for Jefferies—What about Other Cannabis Players?(Continued from Prior Part)Cannabis sector multiplesNow, let’s look at another valuation multiple for the same 12 cannabis players: the forward EV-to-EBITDA (enterprise

Supreme Cannabis Signs LOI with Malta Enterprises for Cannabis License

Letter of intent is the first step to obtain a cannabis production license in Malta. Malta is strategically located to serve export markets throughout Europe. TORONTO, March 11, 2019 /PRNewswire/ - The Supreme Cannabis Company, Inc. ("Supreme Cannabis" or the "Company") (FIRE.TO) (SPRWF) (53S1.F) today announced that the Company has signed a letter of intent ("LOI") with Malta Enterprises, the economic development agency of Malta.

Aurora Cannabis: Ratings and Target Price in March

Analysts' Ratings Change for APHA, ACB, and CRON in March(Continued from Prior Part)Aurora Cannabis Aurora Cannabis (ACB) came under renewed attention. On March 5, Cowen initiated coverage on Aurora Cannabis (ACB) with an “outperform” rating. The